What is EVIO, Inc. (EVIO)?

EVIO, Inc. (EVIO) is a stock in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. View full analysis on Stocks360.

What is the current price of EVIO?

The current price of EVIO is $0.00. Prices are updated in real time on Stocks360.

What is EVIO's price-to-earnings (PE) ratio?

EVIO's trailing twelve-month PE ratio is 1.67, based on current price and earnings per share data available on Stocks360.

What is EVIO's market capitalization?

EVIO's market capitalization is $1,036,577.00, placing it in the small-cap tier.

EVIO, Inc. (EVIO)

Stock analysis · OTC · Healthcare · Drug Manufacturers - Specialty & Generic

$0.00

Market Cap

$1.04M

PE (TTM)

1.67

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

-2.39

Day Range

$0.00 – $0.00

52-wk Range

$0.00 – $0.00

Avg Volume

N/A

Volume

49.00

EVIO, Inc. (EVIO) is a publicly traded company in the Healthcare sector. Latest price: $0.00. Market cap $1.04M. Trailing PE 1.67. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

You have viewed 4 SEO analysis pages

Unlock saved watchlists, personalized setups, and referral credits with a free Stocks360 account.

Continue with free signup

1-Year Price

2025-10-28 · $0.00 2026-10-26 · $0.00 (+0.00%)

Earnings

Most Recent

Aug 16, 2018

EPS $-0.19 vs est. $-0.09

Missed by $0.10

Proprietary Signals

Signal snapshot temporarily unavailable.

About EVIO, Inc.

EVIO, Inc., along with its affiliates, provides specialized analytical testing and expert advisory services to the cannabis industry throughout the United States. The company's consulting expertise spans strategic guidance, product formulation assistance, and comprehensive support for licensing and regulatory compliance. Furthermore, EVIO conducts a full range of laboratory analyses, including cannabinoid potency assessment, terpene profiling, pesticide screening, residual solvent detection, visual inspections, and biological contaminant testing. The firm maintains its headquarters in Henderson, Nevada.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	1.67×
P/S (TTM)	0.65×
P/B	-0.01×
PEG	0.02×
P/FCF (TTM)	-1.44×
EV / EBITDA	12.34×
EV / Sales	5.53×
Earnings Yield	59.79%
Free Cash Flow Yield	-69.36%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$8.80M
Revenue (TTM)	$1.59M
Net Income (TTM)	$619.81K
Free Cash Flow (TTM)	$38.00K
Net Debt	$7.76M
Working Capital	-$8.18M
Gross Margin	33.02%
Operating Margin	-87.04%
Net Margin	3.02%
Return on Equity	-0.36%
Return on Invested Capital	29.93%